Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Bipolar Disorders
Trial Information
Open-label Study of Quetiapine for Mania in Preschool Children 4 to 6
Children between the ages of 4-6 years old who have, or display symptoms of bipolar disorder (explosiveness, mood swings, irritability, or violent behavior) are asked to participate in an 8-week research study to determine the effectiveness and safety of a medication called Seroquel (quetiapine) in the treatment of children with bipolar disorder. After undergoing a comprehensive evaluation by medical doctors with a specialty in this area, children who are found eligible to participate in this research study will be treated with Seroquel and will have weekly visits for 8 weeks in an effort to closely monitor each child’s response to the medication. Eligible participants will receive study-related evaluations and weekly study visits with our study doctors at no cost. Medication costs must be covered by participants and/or their insurance providers.
Eligibility Criteria:
Children ages 4-6 with Bipolar disorder
Sarah Walls
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-724-4MGH
EMail: PPPCresearch@partners.org
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
